# CB Financial Services, Inc.: financial statements, quarterly

CBFV · Nasdaq · CIK 1605301 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbfv.md) · [Financials](/companies/cbfv/financials.md) · [Filings](/companies/cbfv/filings.md) · [Insiders](/companies/cbfv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbfv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [5.2](/filings/0001605301-23-000043.md) | [5.8 d](/filings/0001605301-24-000005.md) | [6.4](/filings/0001605301-24-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.6](/filings/0001605301-24-000043.md) | [5.3 d](/filings/0001605301-25-000008.md) | [0.9](/filings/0001605301-25-000023.md) | [0.6](/filings/0001605301-25-000037.md) | [0.7](/filings/0001605301-25-000045.md) | [0.5 d](/filings/0001605301-26-000009.md) | [0.4](/filings/0001605301-26-000023.md) | [0.8](/filings/0001605301-26-000031.md) | [(1.3)](/filings/0001605301-25-000045.md) | [0.5 d](/filings/0001605301-26-000009.md) | [0.7](/filings/0001605301-26-000023.md) | [0.8](/filings/0001605301-26-000031.md) |
| Net income | $m | [2.7](/filings/0001605301-24-000043.md) | [13.0 d](/filings/0001605301-25-000008.md) | [4.2](/filings/0001605301-25-000023.md) | [2.7](/filings/0001605301-25-000037.md) | [3.2](/filings/0001605301-25-000045.md) | [2.5 d](/filings/0001605301-26-000009.md) | [1.9](/filings/0001605301-26-000023.md) | [3.9](/filings/0001605301-26-000031.md) | [(5.7)](/filings/0001605301-25-000045.md) | [4.7 d](/filings/0001605301-26-000009.md) | [3.9](/filings/0001605301-26-000023.md) | [4.3](/filings/0001605301-26-000031.md) |
| Diluted EPS | $ per share | [0.52](/filings/0001605301-24-000043.md) | not reported | [0.82](/filings/0001605301-25-000023.md) | [0.51](/filings/0001605301-25-000037.md) | [0.60](/filings/0001605301-25-000045.md) | not reported | [0.35](/filings/0001605301-26-000023.md) | [0.74](/filings/0001605301-26-000031.md) | [(1.07)](/filings/0001605301-25-000045.md) | not reported | [0.73](/filings/0001605301-26-000023.md) | [0.80](/filings/0001605301-26-000031.md) |
| Basic EPS | $ per share | [0.52](/filings/0001605301-24-000043.md) | not reported | [0.82](/filings/0001605301-25-000023.md) | [0.52](/filings/0001605301-25-000037.md) | [0.63](/filings/0001605301-25-000045.md) | not reported | [0.37](/filings/0001605301-26-000023.md) | [0.79](/filings/0001605301-26-000031.md) | [(1.14)](/filings/0001605301-25-000045.md) | not reported | [0.77](/filings/0001605301-26-000023.md) | [0.85](/filings/0001605301-26-000031.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.6](/filings/0001605301-23-000043.md) | [68.2](/filings/0001605301-25-000008.md) | [73.7](/filings/0001605301-24-000023.md) | [143](/filings/0001605301-24-000035.md) | [147](/filings/0001605301-24-000043.md) | [49.6](/filings/0001605301-26-000009.md) | [61.3](/filings/0001605301-25-000023.md) | [64.5](/filings/0001605301-25-000037.md) | [55.9](/filings/0001605301-25-000045.md) | [31.7](/filings/0001605301-26-000031.md) | [55.5](/filings/0001605301-26-000023.md) | [76.1](/filings/0001605301-26-000031.md) |
| Total assets | $m | [1,399](/filings/0001605301-23-000043.md) | [1,456](/filings/0001605301-25-000008.md) | [1,473](/filings/0001605301-24-000023.md) | [1,560](/filings/0001605301-24-000035.md) | [1,562](/filings/0001605301-24-000043.md) | [1,482](/filings/0001605301-26-000009.md) | [1,483](/filings/0001605301-25-000023.md) | [1,518](/filings/0001605301-25-000037.md) | [1,546](/filings/0001605301-25-000045.md) | [1,548](/filings/0001605301-26-000031.md) | [1,583](/filings/0001605301-26-000023.md) | [1,656](/filings/0001605301-26-000031.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [1,285](/filings/0001605301-23-000043.md) | [1,316](/filings/0001605301-25-000008.md) | [1,331](/filings/0001605301-24-000023.md) | [1,417](/filings/0001605301-24-000035.md) | [1,413](/filings/0001605301-24-000043.md) | [1,334](/filings/0001605301-26-000009.md) | [1,335](/filings/0001605301-25-000023.md) | [1,370](/filings/0001605301-25-000037.md) | [1,393](/filings/0001605301-25-000045.md) | [1,390](/filings/0001605301-26-000031.md) | [1,425](/filings/0001605301-26-000023.md) | [1,494](/filings/0001605301-26-000031.md) |
| Short-term borrowings | $m | [0.0](/filings/0001605301-23-000043.md) | [0.0](/filings/0001605301-24-000005.md) | not reported | not reported | not reported | [0.0](/filings/0001605301-26-000009.md) | not reported | not reported | not reported | [0.0](/filings/0001605301-26-000031.md) | not reported | [65.0](/filings/0001605301-26-000031.md) |
| Shareholders' equity | $m | [115](/filings/0001605301-24-000043.md) | [140](/filings/0001605301-26-000009.md) | [142](/filings/0001605301-25-000037.md) | [143](/filings/0001605301-25-000045.md) | [149](/filings/0001605301-25-000045.md) | [147](/filings/0001605301-26-000031.md) | [148](/filings/0001605301-26-000031.md) | [148](/filings/0001605301-26-000031.md) | [152](/filings/0001605301-25-000045.md) | [158](/filings/0001605301-26-000031.md) | [159](/filings/0001605301-26-000031.md) | [162](/filings/0001605301-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [9,130 d](/filings/0001605301-24-000043.md) | [(3,430) d](/filings/0001605301-25-000008.md) | [3,260](/filings/0001605301-25-000023.md) | [(1,166) d](/filings/0001605301-25-000037.md) | [3,067 d](/filings/0001605301-25-000045.md) | [1,589 d](/filings/0001605301-26-000009.md) | [4,027](/filings/0001605301-26-000023.md) | [4,132 d](/filings/0001605301-26-000031.md) | [4,621 d](/filings/0001605301-25-000045.md) | [5,027 d](/filings/0001605301-26-000009.md) | [3,018](/filings/0001605301-26-000023.md) | [7,425 d](/filings/0001605301-26-000031.md) |
| Capital expenditure | $k | [249 d](/filings/0001605301-24-000043.md) | [1,699 d](/filings/0001605301-25-000008.md) | [970](/filings/0001605301-25-000023.md) | [1,219 d](/filings/0001605301-25-000037.md) | [856 d](/filings/0001605301-25-000045.md) | [270 d](/filings/0001605301-26-000009.md) | [101](/filings/0001605301-26-000023.md) | [257 d](/filings/0001605301-26-000031.md) | [104 d](/filings/0001605301-25-000045.md) | [188 d](/filings/0001605301-26-000009.md) | [202](/filings/0001605301-26-000023.md) | [66.0 d](/filings/0001605301-26-000031.md) |
| Dividends paid | $k | [1,278 d](/filings/0001605301-24-000043.md) | [1,279 d](/filings/0001605301-25-000008.md) | [1,280](/filings/0001605301-25-000023.md) | [1,286 d](/filings/0001605301-25-000037.md) | [1,284 d](/filings/0001605301-25-000045.md) | [1,280 d](/filings/0001605301-26-000009.md) | [1,281](/filings/0001605301-26-000023.md) | [1,255 d](/filings/0001605301-26-000031.md) | [1,296 d](/filings/0001605301-25-000045.md) | [1,302 d](/filings/0001605301-26-000009.md) | [1,411](/filings/0001605301-26-000023.md) | [1,419 d](/filings/0001605301-26-000031.md) |
| Share repurchases | $k | [0.0 d](/filings/0001605301-24-000043.md) | [516 d](/filings/0001605301-25-000008.md) | [5.0](/filings/0001605301-25-000023.md) | [0.0 d](/filings/0001605301-25-000037.md) | [326 d](/filings/0001605301-25-000045.md) | [634 d](/filings/0001605301-26-000009.md) | [2,378](/filings/0001605301-26-000023.md) | [4,441 d](/filings/0001605301-26-000031.md) | [7.0 d](/filings/0001605301-25-000045.md) | [14.0 d](/filings/0001605301-26-000009.md) | [292](/filings/0001605301-26-000023.md) | [14.0 d](/filings/0001605301-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,119](/filings/0001605301-23-000043.md) | [5,116](/filings/0001605301-24-000023.md) | [5,116](/filings/0001605301-24-000035.md) | [5,127](/filings/0001605301-24-000043.md) | [5,142](/filings/0001605301-25-000023.md) | [5,153](/filings/0001605301-25-000037.md) | [5,347](/filings/0001605301-25-000045.md) | [5,471](/filings/0001605301-26-000023.md) | [5,332](/filings/0001605301-26-000031.md) | [5,320](/filings/0001605301-25-000045.md) | [5,319](/filings/0001605301-26-000023.md) | [5,354](/filings/0001605301-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,081,584 at 2026-08-05, from the cover of the [10-Q filed 2026-08-07](/filings/0001605301-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.